ID
24095
Description
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus
Keywords
Versions (2)
- 7/3/17 7/3/17 -
- 7/25/17 7/25/17 -
Uploaded on
July 25, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
RECAPTURE PHASE ENTRY (UNSCHEDULED) CRFs Roche FVF4168G Macular Edema NCT00473330
RECAPTURE PHASE ENTRY (UNSCHEDULED) CRFs Roche FVF4168G Macular Edema NCT00473330
Description
RECAPTURE PHASE ENTRY (UNSCHEDULED)
Description
RECAPTURE_MONTH [RCAPMO]
Data type
integer
Measurement units
- Visit Month
Alias
- UMLS CUI [1]
- C3846158
Description
INFORM_CONSENT_DT [ICDT, ICDTF]
Data type
date
Measurement units
- DD/MMM/YY
Alias
- UMLS CUI [1]
- C0021430
Similar models
RECAPTURE PHASE ENTRY (UNSCHEDULED) CRFs Roche FVF4168G Macular Edema NCT00473330
C2986440 (UMLS CUI [1,2])